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Abstract The specificity of protein kinases has been shown to 
be influenced by residues near the phosphoaccepting amino acid. 
To examine the determinants for platelet-derived growth factor 
receptor (PDGFR) tyrosine kinase specificity, a peptide library 
with three degenerate positions N-terminal to tyrosine was 
constructed. After reaction with PDGFR, the most abundant 
phosphopeptides were isolated by immunoaffinity chromatogra- 
phy on a column containing monoclonal anti-phosphotyrosine 
antibody. Further separation of bound phosphopeptides with 
reverse-phase HPLC led to the identification of three optimal 
substrates for PDGFR: Ala-Ala-Asn-Ile-Thr-Tyr-Ala-Ala-Arg- 
Arg-Gly, Ala-Ala-Asn-Arg-Thr-Tyr-Ala-Ala-Arg-Arg-Gly and 
Ala-Ala-Leu-Ile-Thr-Tyr-Ala-Ala-Arg-Arg-Gly, where under- 
lined residues are in the degenerate positions of the peptide 
library. Kinetic analyses of the three individual peptides 
(synthesized separately) showed these peptides to be among the 
best reported substrates for PDGFR. Our results expand the 
range of amino acid residues that have been shown to serve as 
recognition elements for receptor tyrosine kinases. 
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1. Introduction 
Protein phosphorylation is a crucial event involved in the 
regulation of intracellular processes and much work has been 
focused on elucidating protein kinase specificity. Synthetic 
peptides have proved to be powerful tools in studying the 
specificity of various protein kinases. Synthetic peptides based 
on known phosphorylation sites of natural substrates have 
been used to study the specificity of protein kinases such as 
cAMP-dependent and cGMP-dependent protein kinases [1-3], 
the Src family of tyrosine kinases [4,5] and receptor tyrosine 
kinases [6,7]. Kinetic analyses have been performed for var- 
ious receptor protein tyrosine kinases using synthetic peptide 
substrates. Epidermal growth factor receptor (EGFR) tyro- 
sine kinase has been shown to phosphorylate substrates such 
as Ile-Glu-Glu-Ala-Tyr-Leu-Gly, and peptides based on phos- 
phorylation sites of insulin ]]-chain [6], p21 r~, and gastrin [8]. 
The platelet-derived growth factor receptor (PDGFR) is less 
extensively characterized. Peptides that have been used as 
substrates for PDGFR include angiotensin II [9] and a peptide 
based on the phosphorylation site of pp60 . . . . .  [10]. 
More recently, degenerate peptide libraries containing ran- 
domized residues adjacent o the phosphoaccepting residue 
have been used to screen for optimal substrate sequences of 
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various protein kinases [ l l  14]. This approach as identified 
optimal substrate sequences that correlate well with previously 
characterized phosphorylation sites for the respective protein 
kinases. For example, peptide library studies on cAMP- 
dependent protein kinase confirmed the presence of the estab- 
lished RRXS motif [15] in optimal substrates [11 13]. 
Songyang et al. [14] showed proximal acidic residues to be 
important determinants for both receptor and non-receptor 
tyrosine kinases, a finding that correlates with the observation 
that a number of known tyrosine phosphorylation sites have 
acidic residues N-terminal to tyrosine [16]. Strategies for 
screening peptide libraries for phosphorylated peptides have 
differed. Till et al. [1l] employed a liquid chromatography- 
electrospray mass spectrometry s stem to identify and quan- 
tify phosphopeptide species in a peptide library with one de- 
generate position. Songyang et al. [13,14] used a ferric chelat- 
ing column to separate phosphorylated peptides from non- 
phosphorylated peptides in a peptide library with eight degen- 
erate positions. Finally, Wu et al. [12] generated peptide 
libraries with five or seven randomized positions according 
to the process described by Lam et al. [17] in which a single 
peptide species is synthesized on an inert bead. After phos- 
phorylation with [7-32P]ATP, these peptide-bound beads were 
dispersed in agarose solution and visualized by autoradio- 
graphy, and highly phosphorylated species were identified 
and characterized. 
We describe here an approach to studying tyrosine kinase 
specificity using a peptide library containing three degenerate 
positions and immobilized monoclonal anti-phosphotyrosine 
antibody to screen for optimal substrates of PDGFR. Sub- 
strates identified in this manner have been confirmed for their 
specificity by in vitro kinetic studies. 
2. Materials and methods 
2.1. General 
The chloromethylstyrene resin, reagents for solid-phase peptide 
synthesis, and tert-butyloxycarbonyl (Boc) derivatives of amino acids 
were purchased from Peninsula Laboratories or from Advanced 
ChemTech. Phosphocellulose P81 discs were from Whatman and 
[7-32P]ATP was from NEN Dupont. Centricon-30 and Microcon-10 
concentrators were purchased from Amicon. Protein concentrations 
were measured using the Pierce Coomassie Plus Protein Assay 
Reagent. Monoclonal anti-phosphotyrosine a tibody resin and DePro 
Peptide Cleavage Kits were purchased from Sigma Chemical Corp. 
Peptide library synthesis was performed on a RAMPS apparatus from 
Dupont, and peptide purifications were performed on an ISCO 2350 
High-Pressure Liquid Chromatography (HPLC) system using Vydac 
C18 semipreparative and analytical columns. Amino acid analyses 
were carried out on a Waters Picotag Amino Acid Analysis System 
after hydrolysis of peptide in 6 N HCI at ll0°C for 24 h. Protein 
sequencing was performed using a Millipore Sequelon-AA Reagent 
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Kit and an Applied Biosystems model 475A Pulsed Liquid Protein 
Sequencer. Radioactivity was measured in a Beckman LS3801 liquid 
scintillation counter. 
Residues Lys-526-Leu-1067 of the cytoplasmic domain of mouse 13- 
PDGFR [18] (cDNA kindly provided by Dr. L.T. Williams, Univer- 
sity of California, San Francisco) were fused to an N-terminal FLAG 
epitope (Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys) [19] and expressed in 
St9 cells using a baculovirus ystem [20]. Purification of PDGFR 
was performed on 1BI anti-FLAG affinity gel resin, which consists 
of murine IgG monoclonal anti-FLAG antibody coupled to agarose. 
2.2. Peptide synthesis 
Individual peptides were prepared by solid-phase synthesis on Mer- 
rifield resin according to standard t-Boc protocols [21] as previously 
described [11]. For the peptide library, three degenerate positions were 
prepared on a RAMPS apparatus according to the 'divide-couple-re- 
combine' strategy [22]. At each degenerate position, 0.4 mmol of 
peptide-resin was divided into 20 parts by weight and each part under- 
went double coupling with a 6-fold excess of activated hydroxybenzo- 
triazole (HOBt) ester of a unique amino acid. Qualitative ninhydrin 
tests [23] after every individual coupling were negative. Upon comple- 
tion of coupling all parts were recombined before proceeding to the 
next cycle. The completed peptide library was deprotected and cleaved 
from the resin by treatment with HF, extracted with 10% acetic acid 
and lyophilized. The individual peptides PR1, PR2, PR3, Control 1, 
and Control 2 were deprotected and cleaved from resin using DcPro 
Peptide Cleavage Kits from Sigma according to the manufacturer's 
specifications. Final purification of all peptides was accomplished by 
reverse-phase HPLC on a Vydac C18 semipreparative column that 
was equilibrated in 0.1% trifluoroacetic acid. Peptides were eluted 
with a gradient of 0 95% solvent B (75% acetonitrile in 0.1% trifluoro- 
acetic acid) and absorbance was measured at 220 nm. Amino acid 
analyses and matrix-assisted laser desorption mass spectra were con- 
sistent with all expected peptide primary structures. 
2.3. Purification o[ PDGFR 
The cytoplasmic domain of PDGFR was purified according to the 
protocol supplied with the IBI Anti-FLAG M2 resin with the follow- 
ing modifications. Anti-FLAG resin was washed once with HNA 
buffer (50 mM HEPES, 150 mM NaC1, 0.02% NaN> pH 7.4), twice 
with 0.1 M glycine-HC1 (pH 3.0) followed by two more washes of 
HNA buffer and two washes of binding buffer (25 mM HEPES, 5 mM 
EDTA, 50 mM NaCI, 0.2% NP-40, 0.2 laM PMSF, 1 lag/ml aprotinin, 
l gg/ml leupeptin, 1 btg/ml pepstatin, pH 7.4). A 1:1 mixture of 
PDGFR lysate and binding buffer was added to the resin and allowed 
to rock for 3 h at 4°C. This was followed by five washes with binding 
buffer, packing of the resin on a 6× 1 cm column, and two washes 
with elution buffer (25 mM HEPES, 150 mM NaCI, 10% glycerol, 0.2 
gM PMSF, 1 ~tg/ml aprotinin, 1 gg/ml leupeptin, 1 mg/ml FLAG 
epitope peptide, pH 7.4). Fractions were collected and assayed for 
tyrosine kinase activity; active fractions were pooled and concentrated 
on a Centricon-30 concentrator. Protein concentrations were meas- 
ured using the Pierce Protein Assay Reagent and concentrated nzyme 
was stored in 40% glycerol at -20°C. 
2.4. Phosphorylation fpeptides 
Phosphorylation assays were carried out according to a modilied 
version of the phosphocellulose paper assay protocol previously de- 
scribed [24]. Reactions were performed in 50 mM Tris-HCl pH 7.4, 10 
mM MgCI> 6 mM MnC12, 1 mg/ml bovine serum albumin, and 200 
l, tM [,t,-a~P]ATP, with varying peptide concentrations. 
To study the kinetics of phosphorylation of individual peptides, 
PDGFR was allowed to autophosphorylate with non-radioactive 
ATP for 60 min at 30°C and reactions were initiated upon addition 
of peptide and [7-32p]ATP. Reactions were carried out in 25 lal vol- 
umes with varying concentrations of substrate, and were incubated at 
30°C. Rates of phosphate transfer to synthetic peptides were meas- 
ured as previously described [24]. Basal levels of enzyme autophos- 
phorylation were subtracted from total phosphorylation levels to ob- 
tain peptide phosphorylation levels. 
2.5. Isolation and identification of tyrosine-phosphorylated peptides 
4 mM peptide library (total peptide concentration) was allowed to 
react with PDGFR under the conditions described above in a volume 
of 1 ml for 1 h at 30°C. Peptides were separated from BSA and 
protein kinase by filtration through a Microcon-10 unit (Amicon). 
The mixture of phosphorylated and unphosphorylated peptides was 
rocked together with anti-phosphotyrosine resin for 2 h at room tem- 
perature. The resin was then packed on a 4×0.5 cm column and 
unbound peptides were removed with ten 2-ml washes of phos- 
phate-buffered saline (pH 7.0). Bound peptides were eluted with three 
2-ml washes of 0.1 M glycine-HC1 (pH 3.5). Fractions were analyzed 
by liquid scintillation counting, and glycine-HCl eluted fractions con- 
taining :~2p were applied to a reverse-phase HPLC column. Peaks of 
absorbance from HPLC were collected and analyzed by liquid scin- 
tillation counting to verify the presence of radioactivity. The se- 
quences of the phosphopeptides were determined by Edman degrada- 
tion. Peptides were linked via their C-termini to Sequelon-AA 
membrane using the Millipore Sequelon-AA Reagent Kit according 
to the manufacturer's specifications. Controls to ensure the specificity 
of the anti-phosphotyrosine resin were performed in an analogous 
manner using unphosphorylated and phosphorylated [LeuS]src-related 
peptide (Arg-Arg-Leu-Ile-Glu-Asp-Ala-Leu-Tyr-Ala-Ala-Arg-Gly) 
[ll]. 
3. Results 
3.1. Synthesis of peptide library 
The peptide library used in this study has the following 
sequence: Ala-Ala-X-X-X-Tyr-Ala-Ala-Arg-Arg-Gly,  where 
X represents an equimolar mixture of all 20 natural ly occur- 
ring amino acids. The library was designed with randomized 
residues N-terminal to tyrosine because substitutions at these 
positions in synthetic peptides have been demonstrated to 
influence phosphorylat ion by receptor and non-receptor tyro- 
sine kinases [11,25,26]. Alanine was chosen as the amino acid 
to flank the randomized positions and tyrosine because it has 
neutral character, lacks hydrogen bonding potential, and is 
relatively flexible. Two arginine residues were included near 
the peptide C-terminus to facilitate binding to phosphocellu- 
lose paper for protein kinase assays [27]. The peptide library 
was synthesized by standard solid-phase synthesis [21], except 
at the randomized positions. For  the degenerate positions, the 
resin was divided into 20 portions and a separate coupling 
reaction was carried out for each amino acid. The desired 
stoichiometry at the randomized positions was verified by 
amino acid analysis (data not shown). 
3.2. Phosphorylation of peptide library" 
As an initial test of the reactivity of the peptide library, 
1 mM peptide library (total peptide concentration) was incu- 
bated with PDGFR in the presence of [~/-32p]ATP. The pro- 
gress of the reaction was followed by the phosphocellulose 
paper binding assay. These results indicated that maximal 
phosphorylat ion of components of the l ibrary occurred after 
60 min of reaction, and that approx. 0.15% of the total pep- 
tide l ibrary was phosphorylated ( ata not shown). The reac- 
tion between the peptide library and PDGFR was analyzed by 
reverse-phase HPLC and scintil lation counting (Fig. 1). These 
data indicated that the major phosphopeptide (or phospho- 
Table 1 
Sequencing of phosphopeptide p aks bl and b2 
Peak bl Peak b2 
Cycle Amino acid Cycle Amino acid 
3 Asn 3 Leu 
4 Arg, lie ~ 4 lie 
5 Thr 5 Thr 
~A lower amount of lie was detected with the major amino acid Arg 
(24% of Arg). 
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Fig. 1. HPLC analysis of PDGFR reaction with peptide library. 
HPLC conditions are described in Section 2. Fractions were col- 
lected every 30 s and analyzed by scintillation counting. 
peptides) eluted from the column at approx. 39.5% solvent B 
(Fig. 1). 
A library reaction with PDGFR was carried out on a larger 
scale to identify peptides phosphorylated bythe enzyme. After 
60 min of reaction, PDGFR was removed from peptides by 
filtration using a Microcon-10 unit (molecular mass cut- 
off= 10 kDa). Phosphorylated peptides in the Microcon-10 
filtrate were separated from unphosphorylated peptides by 
immunoaffinity chromatography using anti-phosphotyrosine 
antibody resin. 
To test the ability of the anti-phosphotyrosine column to 
bind phosphopeptides under the conditions used for our as- 
say, controls were first carried out using phosphorylated and 
unphosphorylated [LeuS]src-related peptide [11]. The phos- 
phorylated version of this peptide was produced by reaction 
with [y-32P]ATP and the v-Abl tyrosine kinase, as previously 
described [11]. Unphosphorylated [LeuS]src-related peptide 
did not bind to antiphosphotyrosine resin under the condi- 
tions of our assay, as determined by HPLC analysis of the 
fractions eluted by 0.1 M glycine-HC1, pH 3.5 (Fig. 2A). In 
contrast, phosphorylated [LeuS]src-related peptide was re- 
tained on the column under the same conditions. The radio- 
active phosphopeptide was eluted from the immunoaffinity 
column by treatment with glycine-HC1 and eluted at 64% B 
on reverse-phase HPLC (data not shown). 
This procedure for binding, washing, and elution was then 
carried out on the products of the peptide library reaction 
with PDGFR. Radioactive fractions eluted from the column 
Table 2 
Kinetic analyses of platelet-derived growth factor receptor kinase 
were pooled and analyzed by reverse-phase HPLC (Fig. 2B), 
Two major peaks of absorbance at 220 nm, bl and b2, eluted 
at 39% and 41% B, respectively. Fractions corresponding to
these peaks were collected for further characterization. Pep- 
tides from peaks bl and b2 were linked via their C-termini 
onto Sequelon-AA membranes and were subjected to 7 cycles 
of Edman sequencing, The most abundant amino acids from 
relevant sequencing cycles are shown (Table 1). Cycles 3 5 
correspond to the degenerate positions. Peak bl has Asn in 
the -3  position, Arg in the -2  position, and Thr in the -1  
position. A small amount of Ile was also observed at the -2  
position (24% of that observed for Arg), suggesting that this 
HPLC peak contained two related phosphopeptides. Peak b2 
has Leu in the -3  position, Ile in the -2  position, and Thr in 
the -1  position. 
3.3. Kinetic analyses 
Individual peptides corresponding to the sequenced phos- 
phopeptides were synthesized to confirm the library results. 
Peptides PR1, PR2 and PR3 correspond to the peptide se- 
quences of peak bl, peak b2, and the minor sequence ob- 
tained from peak bl, respectively. For comparison, a peptide 
with three Glu residues N-terminal to tyrosine (Ala-Ala-Glu- 
Glu-Glu-Tyr-Ala-Ala-Arg-Arg-Gly) was tested as a substrate 
for PDGFR, because peptides with multiple acidic residues 
have previously been shown to be substrates for receptor tyr- 
osine kinases [8,28]. Another peptide containing alanine resi- 
dues N-terminal to tyrosine (Ala-Ala-Ala-Ala-Ala-Tyr-Ala- 
Ala-Arg-Arg-Gly) was synthesized to test residues that are 
not predicted to serve as recognition elements for PDGFR. 
Kinetic analyses with these five peptides were performed using 
the phosphocellulose paper binding assay [27]. Experiments 
were carried out at saturating concentrations of ATP and 
the divalent cations Mg 2+ and Mn 2+ to arrive at values of 
Kin, Vm~x and kc~t for the peptides. All five peptides tested 
served as substrates for the cytoplasmic domain of PDGFR 
(Table 2). The kinetic parameters for the three peptides e- 
lected from the library compare favorably with those of the 
best known peptide substrates for PDGFR (e.g. src-related 
peptide with Km =2 mM, Vm~,=0.004 nmol/min per mg 
[10]). Of the five peptides, PR3 is the best substrate for 
PDGFR, with Km=58.9 JaM and k~tlK,~=977.5 M 1 
min -a. Peptides PR2 and PR3, both of which contained Ile 
at the -2  position and Thr at the -1  position, had the lowest 
Km values of the peptides tested (Table 2). 
4. Discussion 
The use of peptide libraries provides a method to screen 
rapidly for optimal substrates of protein tyrosine kinases. A 
Peptide Sequence Km (~tM) Vm~ (nmol/min per mg) ko~tIKm (M -1 min 1) 
PR 1 AANRTYAARRG ~ 189.4 0.37 120.0 
PR2 AALITYAARRG ~ 53.9 0.59 674.7 
PR3 AANITYAARRG ~ 58.9 0.94 977.5 
Control 1 AAAAAYAARRG 946.5 0.07 4.7 
Control 2 AAEEEYAARRG 719.5 0.10 8.5 
Amino acids are written in single-letter codes. 
'~The underlined amino acids correspond to the degenerate positions in the peptide library. 
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Fig. 2, HPLC analysis of peptides eluted from anti-pbosphotyrosine 
column. Conditions are described in Section 2. (A) Control reaction 
with unphosphorylated [LeuS]src-related peptide. 375 nmol of 
[LeuS]src-related peptide was incubated with anti-phosphotyrosine 
resin, washed, and eluted as described in the text. The eluate was 
applied to an analytical C18 column. (B) Analysis of the products 
of the peptide library reaction with PDGFR. After elution from the 
anti-phosphotyrosine column, phosphopeptides were analyzed under 
identical conditions to (A). 
primary advantage of this approach is the ease with which 
diversity may be generated in the substrate pool. Our peptide 
library with three degenerate positions provides a pool of 
8000 different substrates; each additional degenerate position 
will increase that diversity by a factor of 20. Because mono- 
clonal antibodies against phosphotyrosine are highly specific 
for peptides and proteins containing phosphorylated (vs. un- 
phosphorylated) tyrosine, background levels of unphosphory- 
lated peptide are undetectable in our screening approach [29]. 
In addition, these antibodies have been demonstrated to be 
relatively insensitive to the sequence of amino acids surround- 
ing phosphotyrosine [30]. In our experiments, anti-phospho- 
tyrosine immunoaffinity chromatography appears to select he 
major phosphopeptides from the library reaction with 
PDGFR, as judged by a comparison of Fig. 1 with Fig. 2B. 
The pool of phosphopeptides isolated by immunoaffinity 
chromatography was analyzed further by reverse-phase 
HPLC. The most abundant phosphopeptides were separated 
from each other prior to sequencing. 
Our kinetic studies confirm the effectiveness of this library 
approach. Peptides PR1-PR3 were synthesized according to 
the sequences of the most abundant phosphopeptide species 
(Table 1). Peptides PR2 and PR3 were especially good sub- 
strates, among the best reported for PDGFR (Table 2) [9,10]. 
Kinetic analyses of peptides PR2 and PR3 compare the spec- 
ificity contribution of the two determinants Leu and Asn at 
the -3  position. The Km values for the peptides are similar; 
the V~ ..... and k,,~t/Km values, however, are somewhat higher 
for peptide PR3 (Table 2). In the -2  position, Arg and Ile are 
the two predominant determinants (Table 1), and a compar- 
ison between peptides PR1 and PR3 indicates that Ile is pre- 
ferred approx. 8-fold over Arg according to k,,~tlKm values 
(Table 2). Thr appeared to be the primary determinant in 
the -1  position (Table 1). 
Songyang et al. [14] previously studied PDGFR kinase 
specificity using a peptide library with four randomized posi- 
tions on each side of the acceptor tyrosine. In this case, the 
entire mixture of phosphorylated peptides was sequenced to 
elucidate the N- and C-terminal consensus equences. Their 
results indicated that the preferred residues at the -4 ,  -3 ,  
-2 ,  and -1  positions were all Glu, and for the +1, +2, +3, 
and +4 positions Val, Phe, Ile, and X, respectively, where X 
represents any one of the 20 naturally occurring amino acids 
other than Trp, Cys, Tyr, Ser, or Thr. The observed ifference 
of determinants in the N-terminal positions may be a result of 
the different peptide libraries used. Our library included all 20 
naturally occurring amino acids in the degenerate positions 
and lacked degeneracy for positions C-terminal to the phos- 
phoacceptor tyrosine. The composition of amino acids C- 
terminal to tyrosine may influence preferred eterminants at
N-terminal positions. Whether C-terminal residues and N- 
terminal residues interact separately with catalytic site binding 
pockets, or coordinate to form a single binding unit in the 
interaction with the active site of PDGFR tyrosine kinase, is 
unknown. Although the peptide substrates we used are rela- 
tively small, the contribution of substrate secondary structure, 
if any, to specificity cannot be ruled out. We included in our 
kinetics study a peptide containing three N-terminal acidic 
residues (Control 2) to compare to the peptides with N-ter- 
minal aliphatic hydroxy and hydrophobic side chain residues. 
This peptide was a poorer substrate for PDGFR than pep- 
tides PR1, PR2, and PR3, both in terms of K,n and Vm~x 
(Table 2). This suggests that, at least in the context of this 
peptide sequence, acidic residues at the -1, -2, and -3 positions 
are not the primary determinants of substrate specificity. A 
sequence alignment of mouse PDGFR with the crystal struc- 
ture of apo human insulin receptor kinase [31] suggests that 
residues Val-690, Arg-830, and Thr-901 of PDGFR may in- 
teract with the -1  position of the bound substrate, residue 
His-694 with the -2  position, and residue Lys-697 with the 
3 position (P. Chan and W.T. Miller, unpublished). Struc- 
tural studies of kinase-substrate complexes are needed to de- 
termine whether the N-terminal residues with acidic side 
chains interact with the peptide binding site of PDGFR in a 
manner different han those with hydrophobic and aliphatic 
hydroxy side chains. 
Further diversity in the substrate pool can be easily gener- 
ated by incorporating more degenerate positions in the pep- 
tide library, and the contribution of residues to C-terminal to 
tyrosine to kinase specificity can be explored by adding degen- 
eracy at these sites. Non-naturally occurring amino acids or D- 
amino acids can be added to increase diversity beyond the 
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limits set by the 20 natural amino acids and to explore with 
greater esolution the chemical nature of specificity. This ap- 
proach is relevant o laying the foundation for rational design 
of protein kinase inhibitors. In addition, optimal substrate 
motifs may be used to search available databases for possible 
natural substrates of protein tyrosine kinases. 
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